Nephros (NEPH) Capital Expenditures Growth (1y) (2021 - 2022)
Powered by 
Analysis
Nephros (NEPH) Capital Expenditures Growth (1y) (2021 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | -1.00% |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | -27.50% |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | -0.20% |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 10.38% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 24.20% |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 35.70% |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | 5.88% |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | -9.99% |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | -6.52% |
| 10 | Nephros | 48.31 Mn | 43.62 Mn | 4.03 Mn | - |